2.7. Treatment with MTR OralGem Chemotherapy Enhances Antitumor Effector Responses and Reduces Infiltration of CD4+Foxp3+ Treg Cells in the Syngeneic Mouse Lung Cancer Model. This evidence concerns the gene FOXP3 and lung carcinoma.